- Home
- TLSI vs NECB Comparison
TLSI vs NECB Comparison
Compare TLSI & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSI | NECB |
|---|---|---|
| Founded | 2010 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 274.3M | 310.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | NECB |
|---|---|---|
| Price | $5.43 | $23.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 118.9K | 53.6K |
| Earning Date | 11-13-2025 | 02-02-2026 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.21 |
| Revenue | $40,207,000.00 | ★ $102,569,000.00 |
| Revenue This Year | $55.47 | $2.17 |
| Revenue Next Year | $40.05 | $7.52 |
| P/E Ratio | ★ N/A | $7.20 |
| Revenue Growth | ★ 49.52 | N/A |
| 52 Week Low | $3.42 | $19.27 |
| 52 Week High | $7.95 | $25.93 |
Technical Indicators
Market Signals| Indicator | TLSI | NECB |
|---|---|---|
| Relative Strength Index (RSI) | 38.68 | 53.08 |
| Support Level | $5.24 | $22.61 |
| Resistance Level | $5.87 | $24.20 |
| Average True Range (ATR) | 0.41 | 0.69 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 18.35 | 52.93 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.